Streetbeat News

WSNAF

Wesana Health Holdings Inc

Industry

Testing Laboratories

Open

0.00

Mkt cap

68K

Volume

385

High

0.00

P/E Ratio

-0.07

52-wk high

0.03

Low

0.00

Div yield

N/A

52-wk low

0.00

Australia has become the first country to allow physicians to prescribe MDMA for PTSD and psilocybin for treatment-resistant depression. In the US, lawmakers are seeking to advance drug policy changes as part of the National Defense Authorization Act (NDAA), including medical cannabis access for military veterans. The American Medical Association (AMA) has published language concerning the recently-approved Current Procedural Terminology (CPT) III codes applying to psychedelic-assisted therapies. COMPASS Pathways secured up to $50 million in a new term loan facility with Hercules Capital. AdvisorShares Psychedelics ETF (NYSE:PSIL) opened Monday, July 10 at $2.03, improving from prior Monday 3’s opening at $1.89.

Portfolio Pulse from Lara Goldstein

July 11, 2023 | 3:25 pm

A bipartisan bill has created a $75 million research grant program for the potential treatment of mental health conditions in active duty military members. The Multidisciplinary Association for Psychedelic Studies (MAPS) announced its final agenda for its upcoming event, which will include information on two recently-identified lead compounds. Psychedelics were featured on Anderson Cooper’s CNN show. Several companies, including Silo Pharma, Clearmind, and SciSparc, are developing treatments using psychedelics. The AdvisorShares Psychedelics ETF (PSIL) showed an uptrend.

Portfolio Pulse from Lara Goldstein

July 03, 2023 | 9:01 pm

Wesana Health Holdings (OTCQB:WSNAF) shareholders approved the sale of its SANA-013 development-related assets and other related assets to Lucy Scientific Discovery (NASDAQ:LSDI) and Lucy Scientific Discovery USA Inc. SANA-013 is a proprietary drug delivery protocol using a combination of psilocybin and CBD for the treatment of Major Depressive Disorder.

Portfolio Pulse from Lara Goldstein

June 12, 2023 | 10:53 pm

Richard Nanula, CEO of Lucy Scientific (NASDAQ:LSDI), discusses his career and the company's focus on the psychedelic industry. Lucy Scientific has diversified its portfolio, acquiring drug developer Wesana Health Holdings (OTC:WSNAF) and partnering with High Times. Nanula emphasizes adaptability and readiness to confront new business frontiers.

Portfolio Pulse from Benzinga Cannabis

June 05, 2023 | 9:59 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.